Actively personalized vaccination trial for newly diagnosed glioblastoma. (2019)
Attributed to:
MICA: Immunotherapy for oral cancer prevention and treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41586-018-0810-y
PubMed Identifier: 30568303
Publication URI: http://europepmc.org/abstract/MED/30568303
Type: Journal Article/Review
Volume: 565
Parent Publication: Nature
Issue: 7738
ISSN: 0028-0836